Conditions: Chronic Obstructive Pulmonary Disease COPD
Keywords: Chronic Obstructive Pulmonary Disease COPD patients Exacerbations ICS LABA
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 213
Healthy volunteers: no

Brief summary:
The purpose of this study is to determine whether AZD7624 can reduce acute Chronic Obstructive Pulmonary Disease (COPD) exacerbations in patients on COPD maintenance therapy with a history of frequent acute exacerbations.

Detailed description:

Arms:
arm 1: Active treatment arm 2: Placebo Comparator

Interventions: intervention 1: AZD7624 1.0 mg intervention 2: Placebo
Intervention descriptions: intervention 1: Inhaled AZD7624 solution, 11 mg/mL intervention 2: Inhaled placebo solution

Protocol document: